Duchenne
Entity.
- Evidence
- 28 documents · 15 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 1 May 2026, last seen 7 Oct 2026
- Measured
- 18% of mentions say something specific about it; the rest only name it
- As of
- 8 Oct 2026
Where this comes from
- STAT News · 2026-10-07 · STAT+: In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few (opens the source in a new tab)
- MarketBeat News Feed · 2026-10-07 · Sarepta Therapeutics (NASDAQ:SRPT) Downgraded by Zacks Research to "Strong Sell" (opens the source in a new tab)
- STAT News · 2026-10-07 · ER visits from people born outside the U.S. dropped after ICE raids (opens the source in a new tab)
- AllSci News · 2026-10-06 · Italfarmaco and VeriSIM Life combine AI and HDAC expertise in USD 100m+ drug discovery deal (opens the source in a new tab)
- MarketBeat News Feed · 2026-10-05 · Sarepta Therapeutics (NASDAQ:SRPT) Stock Rating Reaffirmed as Sell by HC Wainwright (opens the source in a new tab)
- PR Newswire · 2026-10-03 · Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrop… (opens the source in a new tab)
- MarketBeat News Feed · 2026-10-03 · PTC Therapeutics (NASDAQ:PTCT) Director Sells 12,000 Shares of Stock (opens the source in a new tab)
- Peter Attia · 2026-10-03 · Myostatin inhibitors and the paradox of larger but weaker muscles (opens the source in a new tab)
- TradingView Ideas · 2026-09-30 · Research 30.09.2026 (opens the source in a new tab)
- The Clinical Trial Vanguard · 2026-09-29 · Keros Therapeutics Enrolls First Patient in Phase 2 Rinvatercept DMD Trial (opens the source in a new tab)
- Chemical & Engineering News · 2026-09-22 · Restoring dystrophin in mice with Duchenne muscular dystrophy (opens the source in a new tab)
- GEN · 2026-09-06 · NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy (opens the source in a new tab)